+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Arthritis Drug"

Drugs for Rheumatoid Arthritis: Global Markets to 2022 - Product Thumbnail Image

Drugs for Rheumatoid Arthritis: Global Markets to 2022

  • Report
  • March 2018
  • 182 Pages
  • Global
From
From
From
From
From
KEVZARA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEVZARA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
REMICADE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ENBREL Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENBREL Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ACTEMRA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ACTEMRA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SIMPONI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SIMPONI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
RITUXAN Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RITUXAN Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ORENCIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ORENCIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
JYSELECA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JYSELECA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Japan SMYRAF Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Japan SMYRAF Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Japan
From
RINVOQ Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RINVOQ Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease. The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more